Correlation Between Fate Therapeutics and Insmed
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Insmed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Insmed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Insmed Inc, you can compare the effects of market volatilities on Fate Therapeutics and Insmed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Insmed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Insmed.
Diversification Opportunities for Fate Therapeutics and Insmed
0.35 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Fate and Insmed is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Insmed Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Insmed Inc and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Insmed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Insmed Inc has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Insmed go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Insmed
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Insmed. In addition to that, Fate Therapeutics is 2.7 times more volatile than Insmed Inc. It trades about -0.11 of its total potential returns per unit of risk. Insmed Inc is currently generating about 0.01 per unit of volatility. If you would invest 7,096 in Insmed Inc on September 25, 2024 and sell it today you would lose (38.00) from holding Insmed Inc or give up 0.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Insmed Inc
Performance |
Timeline |
Fate Therapeutics |
Insmed Inc |
Fate Therapeutics and Insmed Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Insmed
The main advantage of trading using opposite Fate Therapeutics and Insmed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Insmed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insmed will offset losses from the drop in Insmed's long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Insmed vs. Fate Therapeutics | Insmed vs. Caribou Biosciences | Insmed vs. Karyopharm Therapeutics | Insmed vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |